Fresenius Medical Care Stock Cash Flow From Operations
| FME Stock | 42.52 0.55 1.31% |
Fresenius Medical Care fundamentals help investors to digest information that contributes to Fresenius Medical's financial success or failures. It also enables traders to predict the movement of Fresenius Stock. The fundamental analysis module provides a way to measure Fresenius Medical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Fresenius Medical stock.
Fresenius |
Fresenius Medical Care Company Cash Flow From Operations Analysis
Fresenius Medical's Operating Cash Flow reveals the quality of a company's reported earnings and is calculated by deducting company's income taxes from earnings before interest, taxes, and depreciation (EBITDA). In other words, Operating Cash Flow refers to the amount of cash a firm generates from the sales or products or from rendering services. Operating Cash Flow typically excludes costs associated with long-term investments or investment in marketable securities and is usually used by investors or analysts to check on the quality of a company's earnings.
Current Fresenius Medical Cash Flow From Operations | 2.17 B |
Most of Fresenius Medical's fundamental indicators, such as Cash Flow From Operations, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Fresenius Medical Care is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Operating Cash Flow shows the difference between reported income and actual cash flows of the company. If a firm does not have enough cash or cash equivalents to cover its current liabilities, then both investors and management should be concerned about the company having enough liquid resources to meet current and long term debt obligations.
| Competition |
In accordance with the recently published financial statements, Fresenius Medical Care has 2.17 B in Cash Flow From Operations. This is 311.06% higher than that of the Healthcare sector and significantly higher than that of the Medical Care Facilities industry. The cash flow from operations for all Germany stocks is 123.16% lower than that of the firm.
Did you try this?
Run My Watchlist Analysis Now
My Watchlist AnalysisAnalyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like |
| All Next | Launch Module |
Fresenius Fundamentals
| Return On Equity | 0.0608 | |||
| Return On Asset | 0.0277 | |||
| Profit Margin | 0.03 % | |||
| Operating Margin | 0.08 % | |||
| Current Valuation | 21.57 B | |||
| Shares Outstanding | 293.41 M | |||
| Shares Owned By Insiders | 32.16 % | |||
| Shares Owned By Institutions | 38.63 % | |||
| Price To Book | 0.59 X | |||
| Price To Sales | 0.46 X | |||
| Revenue | 19.4 B | |||
| Gross Profit | 5.31 B | |||
| EBITDA | 3.2 B | |||
| Net Income | 894.33 M | |||
| Cash And Equivalents | 556.52 M | |||
| Total Debt | 7.17 B | |||
| Book Value Per Share | 47.68 X | |||
| Cash Flow From Operations | 2.17 B | |||
| Earnings Per Share | 2.34 X | |||
| Price To Earnings To Growth | 1.05 X | |||
| Target Price | 34.6 | |||
| Number Of Employees | 128.04 K | |||
| Beta | 0.9 | |||
| Market Capitalization | 10.4 B | |||
| Total Asset | 35.75 B | |||
| Z Score | 0.6 | |||
| Annual Yield | 0.03 % | |||
| Net Asset | 35.75 B | |||
| Last Dividend Paid | 1.12 |
About Fresenius Medical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Fresenius Medical Care's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Fresenius Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Fresenius Medical Care based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Fresenius Stock Analysis
When running Fresenius Medical's price analysis, check to measure Fresenius Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Fresenius Medical is operating at the current time. Most of Fresenius Medical's value examination focuses on studying past and present price action to predict the probability of Fresenius Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Fresenius Medical's price. Additionally, you may evaluate how the addition of Fresenius Medical to your portfolios can decrease your overall portfolio volatility.